Clinical burden and healthcare resource utilization associated with achondroplasia: a real-world observational, retrospective cohort study
Kenneth I. Berger(New York University), Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Gandarvaka Miles(Sanofi (United States)), Kalyani Hawaldar(IQVIA (United States)), Cemre Robinson(Morristown Medical Center)
Cited by 0
Related Papers
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery
|CHEST Journal|2013|901
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
|The Journal of Pediatrics|2006|364
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Respiratory and sleep disorders in mucopolysaccharidosis
|Journal of Inherited Metabolic Disease|2012|158
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance
|Orphanet Journal of Rare Diseases|2019|114